Lentivirus Vector-Based Gene Therapy to Treat Phenylketonuria - American Gene Technologies

American Gene Technologies

Developing Therapeutics That Teach the Body to Heal Itself

AGT Investors
Pipeline
Technology
Resources
Media
- News Releases
- In The News
About Us
Careers
Store
HIV Countdown

Navigation

AGT Investors
Pipeline
Technology
Resources
Media
- News Releases
- In The News
About Us
Careers
Store
HIV Countdown

(click image to view larger - click here to download)

200309-AGT-PKU-Kelly-Poster-Final-No-9-copy

Read The Original Press Release

Get In Touch

American Gene Technologies Inc.

9713 Key West Ave, 5th floor, Rockville, MD 20850
Phone: (301) 337-2100
Fax: (301) 337-2101

Follow Us

Contact Us

Sign-up For Our Newsletter

We send out quarterly newsletters that keep you up-to-date on all our projects, progress, and events.

Sign-Up For Our Newsletter

Follow Us on Social Media

Investors

Corporate Profile
Schedule Investor Relations Appointment
(240) 398-4729

Pipeline

Overview
HIV
Phenylketonuria (PKU)
Immuno-Oncology

Technology

Overview
Rapid Drug Development
Genetic Technologies
Gamma Delta T Cell Therapy For Cancer – ImmunoTox

Media

Overview
Press Releases
Newsletters
Videos & Audio
Gene and Cell Therapy for Young Minds
Published Articles
Blog

About Us

Overview
Leadership Team
Scientific & Clinical Advisors
In Memoriam: Dr. Roscoe Brady
History
Careers
Contact Us

Have a question? Visit our knowledge base for instant and current answers.

Copyright © 2022 American Gene Technologies^® | Privacy Policy

Home
AGT Investors
Pipeline
Technology
Resources
Media
About Us
Careers
AGT Store